Similar articles

• P53, cell cycle control and apoptosis: implications for cancer.

  Kastan MB, Canman CE, Leonard CJ. Kastan MB, et al. Cancer Metastasis Rev. 1995 Mar;14(1):3-15. doi: 10.1007/BF00690207. Cancer Metastasis Rev. 1995. PMID: 7606818 Review.
• [TP53 tumor suppressor gene: 20 years (and ten thousand mutations) later].

  Hainaut P. Hainaut P. Bull Cancer. 2000 Jan;87(1):11-8. Bull Cancer. 2000. PMID: 10673626 French. No abstract available.
• Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215.

  Georges SA, Biery MC, Kim SY, Schelter JM, Guo J, Chang AN, Jackson AL, Carleton MO, Linsley PS, Cleary MA, Chau BN. Georges SA, et al. Cancer Res. 2008 Dec 15;68(24):10105-12. doi: 10.1158/0008-5472.CAN-08-1846. Cancer Res. 2008. PMID: 19074876
• To pop or not to pop: p53 as a critical modulator of tumour responsiveness to therapy in vivo?

  Workman P. Workman P. Hum Exp Toxicol. 1995 Feb;14(2):222-5. doi: 10.1177/096032719501400213. Hum Exp Toxicol. 1995. PMID: 7779451 Review. No abstract available.
• Apoptosis in carcinogenesis: the role of p53.

  Wyllie AH, Carder PJ, Clarke AR, Cripps KJ, Gledhill S, Greaves MF, Griffiths S, Harrison DJ, Hooper ML, Morris RG, et al. Wyllie AH, et al. Cold Spring Harb Symp Quant Biol. 1994;59:403-9. doi: 10.1101/sqb.1994.059.01.045. Cold Spring Harb Symp Quant Biol. 1994. PMID: 7587094 No abstract available.